Do analysts recommend DRMA or SNYR?

Synergy CHC has a consensus price target of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, analysts plainly believe Synergy CHC is more favorable than Dermata Therapeutics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dermata Therapeutics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Do analysts rate ATPC or SNYR?

Synergy CHC has a consensus target price of $6.25, indicating a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, analysts plainly believe Synergy CHC is more favorable than Agape ATP. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Is ATPC or SNYR more profitable?

Synergy CHC has a net margin of -60.02% compared to Agape ATP's net margin of -85.94%. Synergy CHC's return on equity of 0.00% beat Agape ATP's return on equity. Company Net Margins Return on Equity Return on Assets Agape ATP -85.94% -5.47% -4.94% Synergy CHC -60.02% N/A -30.30%

Do analysts recommend SNYR or DSYWW?

Synergy CHC presently has a consensus target price of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, equities analysts clearly believe Synergy CHC is more favorable than Big Tree Cloud. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Big Tree Cloud 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation & earnings, SNYR or DSYWW?

Big Tree Cloud has lower revenue, but higher earnings than Synergy CHC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synergy CHC $27.70M 0.05 -$12.34M -$1.40 N/A Big Tree Cloud $2.02M N/A N/A N/A N/A

Is SNYR or DSYWW more profitable?

Big Tree Cloud has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%. Company Net Margins Return on Equity Return on Assets Synergy CHC -60.02% N/A -30.30% Big Tree Cloud N/A N/A N/A

Do analysts recommend SNYR or PRENW?

Synergy CHC presently has a consensus target price of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher probable upside, research analysts clearly believe Synergy CHC is more favorable than Prenetics Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Prenetics Global 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings & valuation, SNYR or PRENW?

Prenetics Global has higher revenue and earnings than Synergy CHC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synergy CHC $27.70M 0.05 -$12.34M -$1.40 N/A Prenetics Global $154.59M N/A N/A N/A N/A

Is SNYR or PRENW more profitable?

Prenetics Global has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%. Company Net Margins Return on Equity Return on Assets Synergy CHC -60.02% N/A -30.30% Prenetics Global N/A N/A N/A

Do analysts recommend SNYR or WALDW?

Synergy CHC presently has a consensus target price of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, analysts clearly believe Synergy CHC is more favorable than Waldencast. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Waldencast 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, SNYR or WALDW?

Waldencast has higher revenue and earnings than Synergy CHC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synergy CHC $27.70M 0.05 -$12.34M -$1.40 N/A Waldencast $237.32M N/A N/A N/A N/A

Is SNYR or WALDW more profitable?

Waldencast has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%. Company Net Margins Return on Equity Return on Assets Synergy CHC -60.02% N/A -30.30% Waldencast N/A N/A N/A

Synergy CHC (SNYR) Competitors

$0.09 0.00 (0.00%)

As of 09/18/2026

Compare

SNYR vs. DRMA, ATPC, DSYWW, PRENW, and WALDW

Should you buy Synergy CHC stock or one of its competitors? Synergy CHC's main competitors and comparable companies include Dermata Therapeutics (DRMA), Agape ATP (ATPC), Big Tree Cloud (DSYWW), Prenetics Global (PRENW), and Waldencast (WALDW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does Synergy CHC compare to Dermata Therapeutics?

Dermata Therapeutics (NASDAQ:DRMA) and Synergy CHC (NASDAQ:SNYR) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

Dermata Therapeutics has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%. Synergy CHC's return on equity of 0.00% beat Dermata Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dermata Therapeutics	N/A	-166.66%	-130.13%
Synergy CHC	-60.02%	N/A	-30.30%

Dermata Therapeutics has higher earnings, but lower revenue than Synergy CHC. Dermata Therapeutics is trading at a lower price-to-earnings ratio than Synergy CHC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dermata Therapeutics	N/A	N/A	-$7.56M	-$4.39	N/A
Synergy CHC	$27.70M	0.05	-$12.34M	-$1.40	N/A

In the previous week, Dermata Therapeutics had 1 more articles in the media than Synergy CHC. MarketBeat recorded 1 mentions for Dermata Therapeutics and 0 mentions for Synergy CHC. Dermata Therapeutics' average media sentiment score of 0.60 beat Synergy CHC's score of 0.00 indicating that Dermata Therapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
Dermata Therapeutics	Positive
Synergy CHC	Neutral

Dermata Therapeutics has a beta of 0.66, suggesting that its stock price is 34% less volatile than the broader market. Comparatively, Synergy CHC has a beta of -0.25, suggesting that its stock price is 125% less volatile than the broader market.

Synergy CHC has a consensus price target of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, analysts plainly believe Synergy CHC is more favorable than Dermata Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dermata Therapeutics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

8.7% of Dermata Therapeutics shares are owned by institutional investors. 21.9% of Dermata Therapeutics shares are owned by insiders. Comparatively, 32.9% of Synergy CHC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Synergy CHC beats Dermata Therapeutics on 8 of the 14 factors compared between the two stocks.

How does Synergy CHC compare to Agape ATP?

Agape ATP (NASDAQ:ATPC) and Synergy CHC (NASDAQ:SNYR) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

0.0% of Agape ATP shares are held by institutional investors. 2.0% of Agape ATP shares are held by insiders. Comparatively, 32.9% of Synergy CHC shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Synergy CHC has a consensus target price of $6.25, indicating a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, analysts plainly believe Synergy CHC is more favorable than Agape ATP.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Agape ATP has a beta of 0.42, meaning that its stock price is 58% less volatile than the broader market. Comparatively, Synergy CHC has a beta of -0.25, meaning that its stock price is 125% less volatile than the broader market.

Synergy CHC has a net margin of -60.02% compared to Agape ATP's net margin of -85.94%. Synergy CHC's return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agape ATP	-85.94%	-5.47%	-4.94%
Synergy CHC	-60.02%	N/A	-30.30%

Agape ATP has higher earnings, but lower revenue than Synergy CHC. Agape ATP is trading at a lower price-to-earnings ratio than Synergy CHC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agape ATP	$1.52M	1.28	-$2.28M	-$0.74	N/A
Synergy CHC	$27.70M	0.05	-$12.34M	-$1.40	N/A

In the previous week, Agape ATP had 3 more articles in the media than Synergy CHC. MarketBeat recorded 3 mentions for Agape ATP and 0 mentions for Synergy CHC. Agape ATP's average media sentiment score of 0.94 beat Synergy CHC's score of 0.00 indicating that Agape ATP is being referred to more favorably in the media.

Company	Overall Sentiment
Agape ATP	Positive
Synergy CHC	Neutral

Summary

Agape ATP and Synergy CHC tied by winning 8 of the 16 factors compared between the two stocks.

How does Synergy CHC compare to Big Tree Cloud?

Synergy CHC (NASDAQ:SNYR) and Big Tree Cloud (NASDAQ:DSYWW) are both consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

Big Tree Cloud has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%.

Company	Net Margins	Return on Equity	Return on Assets
Synergy CHC	-60.02%	N/A	-30.30%
Big Tree Cloud	N/A	N/A	N/A

In the previous week, Big Tree Cloud had 1 more articles in the media than Synergy CHC. MarketBeat recorded 1 mentions for Big Tree Cloud and 0 mentions for Synergy CHC. Big Tree Cloud's average media sentiment score of 1.82 beat Synergy CHC's score of 0.00 indicating that Big Tree Cloud is being referred to more favorably in the news media.

Company	Overall Sentiment
Synergy CHC	Neutral
Big Tree Cloud	Very Positive

Big Tree Cloud has lower revenue, but higher earnings than Synergy CHC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$27.70M	0.05	-$12.34M	-$1.40	N/A
Big Tree Cloud	$2.02M	N/A	N/A	N/A	N/A

Synergy CHC presently has a consensus target price of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, equities analysts clearly believe Synergy CHC is more favorable than Big Tree Cloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Big Tree Cloud	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Synergy CHC and Big Tree Cloud tied by winning 4 of the 8 factors compared between the two stocks.

How does Synergy CHC compare to Prenetics Global?

Synergy CHC (NASDAQ:SNYR) and Prenetics Global (NASDAQ:PRENW) are both consumer staples companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Prenetics Global has higher revenue and earnings than Synergy CHC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$27.70M	0.05	-$12.34M	-$1.40	N/A
Prenetics Global	$154.59M	N/A	N/A	N/A	N/A

Prenetics Global has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%.

Company	Net Margins	Return on Equity	Return on Assets
Synergy CHC	-60.02%	N/A	-30.30%
Prenetics Global	N/A	N/A	N/A

Synergy CHC presently has a consensus target price of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher probable upside, research analysts clearly believe Synergy CHC is more favorable than Prenetics Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Prenetics Global	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Prenetics Global had 3 more articles in the media than Synergy CHC. MarketBeat recorded 3 mentions for Prenetics Global and 0 mentions for Synergy CHC. Prenetics Global's average media sentiment score of 1.14 beat Synergy CHC's score of 0.00 indicating that Prenetics Global is being referred to more favorably in the news media.

Company	Overall Sentiment
Synergy CHC	Neutral
Prenetics Global	Positive

Summary

Prenetics Global beats Synergy CHC on 5 of the 8 factors compared between the two stocks.

How does Synergy CHC compare to Waldencast?

Synergy CHC (NASDAQ:SNYR) and Waldencast (NASDAQ:WALDW) are both consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

Waldencast has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%.

Company	Net Margins	Return on Equity	Return on Assets
Synergy CHC	-60.02%	N/A	-30.30%
Waldencast	N/A	N/A	N/A

In the previous week, Waldencast had 2 more articles in the media than Synergy CHC. MarketBeat recorded 2 mentions for Waldencast and 0 mentions for Synergy CHC. Waldencast's average media sentiment score of 1.39 beat Synergy CHC's score of 0.00 indicating that Waldencast is being referred to more favorably in the news media.

Company	Overall Sentiment
Synergy CHC	Neutral
Waldencast	Positive

Synergy CHC presently has a consensus target price of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, analysts clearly believe Synergy CHC is more favorable than Waldencast.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Waldencast	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Waldencast has higher revenue and earnings than Synergy CHC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$27.70M	0.05	-$12.34M	-$1.40	N/A
Waldencast	$237.32M	N/A	N/A	N/A	N/A

Summary

Waldencast beats Synergy CHC on 5 of the 8 factors compared between the two stocks.

Get Synergy CHC News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNYR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SNYR vs. The Competition

Export

Metric	Synergy CHC	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$1.37M	$23.92B	$16.31B	$12.93B
Dividend Yield	N/A	5.37%	3.29%	22.89%
P/E Ratio	-0.06	22.22	13.96	25.30
Price / Sales	0.05	13.37	264,297.16	76.35
Price / Cash	N/A	26.71	57.21	53.04
Price / Book	-0.04	3.48	4.45	5.92
Net Income	-$12.34M	$1.13B	$844.17M	$381.04M
7 Day Performance	N/A	-0.01%	0.88%	-4.38%
1 Month Performance	N/A	-6.00%	-2.50%	-7.25%
1 Year Performance	N/A	-21.10%	9.67%	-4.95%

Synergy CHC Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SNYR Synergy CHC	1.8569 of 5 stars	$0.09 flat	$6.25 +6,806.1%	N/A	$1.37M	$27.70M	N/A	40
DRMA Dermata Therapeutics	0.9816 of 5 stars	$1.12 -0.9%	N/A	-79.6%	$4.50M	N/A	N/A	9
ATPC Agape ATP	1.1118 of 5 stars	$2.03 -2.4%	N/A	-96.8%	$2.03M	$1.32M	N/A	18	Short Interest Decrease Gap Up
DSYWW Big Tree Cloud	N/A	$0.02 +11.8%	N/A	-53.7%	$0.00	$2.02M	N/A	20	Gap Up
PRENW Prenetics Global	N/A	$0.01 +10.1%	N/A	-69.4%	$0.00	$154.59M	N/A	1	Short Interest Decrease Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SNYR) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synergy CHC (SNYR) Competitors

SNYR vs. DRMA, ATPC, DSYWW, PRENW, and WALDW

How does Synergy CHC compare to Dermata Therapeutics?

Summary

How does Synergy CHC compare to Agape ATP?

Summary

How does Synergy CHC compare to Big Tree Cloud?

Summary

How does Synergy CHC compare to Prenetics Global?

Summary

How does Synergy CHC compare to Waldencast?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNYR vs. The Competition

Synergy CHC Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Synergy CHC (SNYR) Competitors

SNYR vs. DRMA, ATPC, DSYWW, PRENW, and WALDW

How does Synergy CHC compare to Dermata Therapeutics?

Is DRMA or SNYR more profitable?

Which has better earnings & valuation, DRMA or SNYR?

Does the media prefer DRMA or SNYR?

Which has more volatility and risk, DRMA or SNYR?

Do analysts recommend DRMA or SNYR?

Do institutionals and insiders hold more shares of DRMA or SNYR?

Summary

How does Synergy CHC compare to Agape ATP?

Do institutionals and insiders have more ownership in ATPC or SNYR?

Do analysts rate ATPC or SNYR?

Which has more volatility & risk, ATPC or SNYR?

Is ATPC or SNYR more profitable?

Which has preferable valuation and earnings, ATPC or SNYR?

Does the media refer more to ATPC or SNYR?

Summary

How does Synergy CHC compare to Big Tree Cloud?

Is SNYR or DSYWW more profitable?

Does the media refer more to SNYR or DSYWW?

Which has preferable valuation & earnings, SNYR or DSYWW?

Do analysts recommend SNYR or DSYWW?

Summary

How does Synergy CHC compare to Prenetics Global?

Which has better earnings & valuation, SNYR or PRENW?

Is SNYR or PRENW more profitable?

Do analysts recommend SNYR or PRENW?

Does the media refer more to SNYR or PRENW?

Summary

How does Synergy CHC compare to Waldencast?

Is SNYR or WALDW more profitable?

Does the media refer more to SNYR or WALDW?

Do analysts recommend SNYR or WALDW?

Which has stronger earnings and valuation, SNYR or WALDW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNYR vs. The Competition

Synergy CHC Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools